Home

Ohne Zweifel Tod beachten ara cell fachinformation Entscheidung Urteil Penny

MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly
MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly

ARA-cell® | STADA
ARA-cell® | STADA

Natalija Novak's research works | University of Bonn, Bonn (Uni Bonn) and other places
Natalija Novak's research works | University of Bonn, Bonn (Uni Bonn) and other places

STADApharm
STADApharm

QuapoS 4 - ESOP | European Society of Oncology Pharmacy
QuapoS 4 - ESOP | European Society of Oncology Pharmacy

ARA-cell 1000 mg/4000 mg Infusionslösung
ARA-cell 1000 mg/4000 mg Infusionslösung

ARA-cell® 1000 mg Infusionslösung
ARA-cell® 1000 mg Infusionslösung

Anhang
Anhang

Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä

Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä

US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents
US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents

Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human - ScienceDirect
Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human - ScienceDirect

Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules

Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste

Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews

Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews

Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules

Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human - ScienceDirect
Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human - ScienceDirect

ARA-cell 100 mg/ml Konzentrat
ARA-cell 100 mg/ml Konzentrat

Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink
Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink

Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules

A Clinical Drugâ•'Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin
A Clinical Drugâ•'Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin

MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly
MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly

Informationen zur zweckmäßigen Vergleichstherapie
Informationen zur zweckmäßigen Vergleichstherapie

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy. - Abstract - Europe PMC
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy. - Abstract - Europe PMC